< Back

'juvenile rheumatoid arthritis'
Run an advanced search on this term

Search within:  

Sort results by:      



1-8 of 8  
 
1.  
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis. 2015 Dec 16. NGC:010878
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Best evidence statement (BESt). Screening for uveitis in children with juvenile idiopathic arthritis (JIA). 2012 Jun 18. NGC:009274
Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. View all guidelines by the developer(s)
3.  
Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198). 2010 Aug (revised 2012 Feb). NGC:009080
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
ACR Appropriateness Criteria® limping child — ages 0-5 years. 1995 (revised 2012). NGC:009219
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
7.  
Assessment and management of chronic pain. 2005 Nov (revised 2013 Nov). NGC:010140
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
8.  
Knee & leg (acute & chronic). 2003 (revised 2013 Nov 29). NGC:010120
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
1-8 of 8